These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7920571)

  • 1. [Studies on the quality of enzyme preparations (XII)--lysozyme preparations].
    Yokota I; Ohta M; Tanimoto T; Hayakawa T
    Eisei Shikenjo Hokoku; 1993; (111):75-7. PubMed ID: 7920571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lysozyme Reference Standard (Control 031) of National Institute of Health Sciences].
    Kaihara A; Murakami M; Morita Y; Koide T; Murai T; Saito H; Tanimoto T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2003; (121):76-7. PubMed ID: 14740415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational and quantitative characterization of lysozyme extracted from galyfilcon and senofilcon silicone hydrogel contact lenses.
    Glasier MA; Keech A; Sheardown H; Subbaraman LN; Jones L
    Curr Eye Res; 2008 Jan; 33(1):1-11. PubMed ID: 18214737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction efficiency of an extraction buffer used to quantify lysozyme deposition on conventional and silicone hydrogel contact lens materials.
    Subbaraman LN; Glasier MA; Senchyna M; Sheardown H; Jones L
    Eye Contact Lens; 2007 Jul; 33(4):169-73. PubMed ID: 17630622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?
    Wohlfarth K; Sycha T; Ranoux D; Naver H; Caird D
    Curr Med Res Opin; 2009 Jul; 25(7):1573-84. PubMed ID: 19463043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the quality of enzyme preparations (XI)--Kallidinogenase preparations].
    Tanimoto T; Ohta M; Kawasaki N; Tanaka A
    Eisei Shikenjo Hokoku; 1990; (108):20-5. PubMed ID: 1364355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing recombinant human lysozyme extraction and cation exchange adsorption.
    Wilken LR; Nikolov ZL
    Biotechnol Prog; 2006; 22(3):745-52. PubMed ID: 16739958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave-assisted extraction of active pharmaceutical ingredient from solid dosage forms.
    Hoang TH; Sharma R; Susanto D; Di Maso M; Kwong E
    J Chromatogr A; 2007 Jul; 1156(1-2):149-53. PubMed ID: 17350639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assay of enzyme preparations (I) lysozyme preparations (author's transl)].
    Tanimoto T; Fukuda H; Kawamura J
    Eisei Shikenjo Hokoku; 1980; 98():87-91. PubMed ID: 7248631
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of an ELISA for quantifying lysozyme in hen egg white.
    Vidal ML; Gautron J; Nys Y
    J Agric Food Chem; 2005 Apr; 53(7):2379-85. PubMed ID: 15796566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lysozyme Reference Standard (Control 951) of the National Institute of Health Sciences].
    Kitajima A; Tagashira Y; Maekawa K; Tanimoto T; Okada S
    Eisei Shikenjo Hokoku; 1996; (114):128-9. PubMed ID: 9037882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of egg white lysozyme by on-line coupled capillary isotachophoresis with capillary zone electrophoresis.
    Kvasnicka F
    Electrophoresis; 2003 Mar; 24(5):860-4. PubMed ID: 12627448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the determination of potency of commercial lysozyme preparations (author's transl)].
    Tanimoto T; Yokota I; Nakaji Y; Kawamura J
    Eisei Shikenjo Hokoku; 1978; (96):103-5. PubMed ID: 750026
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of lysozyme activity by a fluorescence technique in comparison with the classical turbidity assay.
    Helal R; Melzig MF
    Pharmazie; 2008 Jun; 63(6):415-9. PubMed ID: 18604983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations.
    Motwani SK; Chopra S; Ahmad FJ; Khar RK
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Oct; 68(2):250-6. PubMed ID: 17329154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
    Shao Y; Alluri R; Mummert M; Koetter U; Lech S
    J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC determination of sodium cromoglycate in pharmaceutical dosage forms.
    Radulović D; Kocić-Pesić V; Pećanac D; Zivanović L
    Farmaco; 1994 May; 49(5):375-6. PubMed ID: 8080622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of insulin in innovative formulations by means of LC coupled to fluorescence detection.
    Mercolini L; Musenga A; Saladini B; Bigucci F; Luppi B; Zecchi V; Raggi MA
    J Pharm Biomed Anal; 2008 Dec; 48(5):1303-9. PubMed ID: 18952391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms.
    Chaibva FA; Walker RB
    J Pharm Biomed Anal; 2007 Jan; 43(1):179-85. PubMed ID: 16920323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.